Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - INVO Bioscience, Inc. | ex_185396.htm |
EX-31.1 - EXHIBIT 31.1 - INVO Bioscience, Inc. | ex_185395.htm |
EX-10.3 - EXHIBIT 10.3 - INVO Bioscience, Inc. | ex_186029.htm |
EX-10.2 - EXHIBIT 10.2 - INVO Bioscience, Inc. | ex_186028.htm |
EX-10.1 - EXHIBIT 10.1 - INVO Bioscience, Inc. | ex_186027.htm |
EX-4.3 - EXHIBIT 4.3 - INVO Bioscience, Inc. | ex_186026.htm |
EX-4.2 - EXHIBIT 4.2 - INVO Bioscience, Inc. | ex_186025.htm |
EX-4.1 - EXHIBIT 4.1 - INVO Bioscience, Inc. | ex_186024.htm |
10-Q - FORM 10-Q - INVO Bioscience, Inc. | invobio20200331_10q.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of INVO Bioscience, Inc. (the “Company”) for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Kathleen Karloff, Chief and Principal Executive Officer of the Company, and Debra Hoopes, Acting Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
INVO BIOSCIENCE |
|
|
|
|
|
|
Date: May 15, 2020 |
By: |
/s/ Steven Shum |
|
|
|
Steven Shum |
|
|
|
Chief Executive Officer |
|
|
|
|
|
|
INVO BIOSCIENCE |
|
|
|
|
|
|
Date: May 15, 2020 |
By: |
/s/ Debra Hoopes |
|
|
|
Debra Hoopes |
|
|
|
Acting Chief Financial Officer |
|
|
|
|
|